FDA Inspects Mesa Laboratories Facility Amid Financial Restructuring
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Food and Drug Administration conducted an inspection of Mesa Laboratories' facility in Bozeman on November 9, 2026. Separately, Mesa Laboratories reported higher revenue and earnings for its fiscal 2027 second quarter. The company also issued full-year guidance, expecting fiscal 2027 revenue between $250 million and $255 million.
From dailypolitical.com
Why it matters
Mesa Laboratories plans to restructure its Clinical Genomics business and repurchase up to $40 million in shares. The company noted that manufacturing issues, including sterilization and disinfection control, remain incomplete on some product lines.
From dailypolitical.com
Who's involved
- Food and Drug AdministrationGovernment agency that conducted the facility inspection